Diadexus Inc (DDXSQ) financial statements (2021 and earlier)

Company profile

Business Address 349 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9151714
Cash and cash equivalents9151713
Short-term investments   1
Receivables2433
Inventory, net of allowances, customer advances and progress billings0100
Inventory0100
Deferred rent asset  00
Prepaid expense and other current assets1
Assets held-for-sale 0
Other undisclosed current assets010(0)
Total current assets:11202118
Noncurrent Assets
Property, plant and equipment0111
Restricted cash and investments1111
Other noncurrent assets000
Prepaid expense and other noncurrent assets0
Total noncurrent assets:2223
TOTAL ASSETS:13222420
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2544
Accounts payable1110
Accrued liabilities1322
Employee-related liabilities 111
Taxes payable  00
Debt14130
Deferred revenue and credits0000
Other liabilities 000
Other undisclosed current liabilities1(1)(1)(1)
Total current liabilities:17674
Noncurrent Liabilities
Long-term debt and lease obligation 1475
Long-term debt, excluding current maturities 1475
Liabilities, other than long-term debt1233
Deferred revenue and credits0001
Off-market lease, unfavorable 122
Other liabilities0000
Total noncurrent liabilities:115108
Total liabilities:18211612
Stockholders' equity
Stockholders' equity attributable to parent(5)189
Common stock0111
Additional paid in capital211209207206
Accumulated deficit(216)(208)(200)(198)
Total stockholders' equity:(5)189
TOTAL LIABILITIES AND EQUITY:13222420

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues18262521
Revenue, net18262518
Cost of revenue
(Cost of Goods and Services Sold)
(5)(8)(8)(6)
Gross profit:13191714
Operating expenses(18)(28)(19)(17)
Other undisclosed operating income 200
Operating loss:(5)(7)(2)(2)
Nonoperating income (expense)(0)000
Investment income, nonoperating0000
Other nonoperating income (expense)(0)00(0)
Interest and debt expense(2)(2)(0)(0)
Loss from continuing operations before income taxes:(7)(8)(2)(3)
Income tax expense(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(7)(8)(2)(3)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(7)(8)(2)(3)
Comprehensive loss:(7)(8)(2)(3)
Other undisclosed comprehensive income, net of tax, attributable to parent   0
Comprehensive loss, net of tax, attributable to parent:(7)(8)(2)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: